Diagnosed with cutaneous vasculitis, urticaria, psoriasis, acne, bullous skin diseases, sterile pustulosis, leprosy, pneumocystis pneumonia and any other patients who need dapsone administration.
Subjects are dapsone-naive.
All subjects must have a clinical need for treatment with dapsone that precedes the decision to participate in the study.
All subjects are willing to complete the 6-weeks period clinical trial.
All subjects are written informed consent.
